RLFTY (MindMaze Therapeutics Holding) PB Ratio: 1.34 (As of Jul. 02, 2026)


RLFTY MindMaze Therapeutics Holding SA RLFTY
11 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is MindMaze Therapeutics Holding PB Ratio?

MindMaze Therapeutics Holding RLFTY 11 PB Ratio is 1.34 as of Jul. 02, 2026. GuruFocus rates RLFTY with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 1,228 Biotechnology companies, MindMaze Therapeutics Holding ranks better than 86.48% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-02), MindMaze Therapeutics Holding's share price is $0.4225. MindMaze Therapeutics Holding's Book Value per Share for the quarter that ended in Dec. 2025 was $0.32. Hence, MindMaze Therapeutics Holding's PB Ratio of today is 1.34.

The historical rank and industry rank for MindMaze Therapeutics Holding's PB Ratio or its related term are showing as below:

RLFTY' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.86
Current: 0.86

During the past 2 years, MindMaze Therapeutics Holding's highest PB Ratio was 0.86. The lowest was 0.00. And the median was 0.00.

RLFTY's PB Ratio is ranked better than
86.48% of 1228 companies
in the Biotechnology industry
Industry Median: 2.95 vs RLFTY: 0.86

During the past 12 months, MindMaze Therapeutics Holding's average Book Value Per Share Growth Rate was 3485.70% per year.

Back to Basics: PB Ratio

MindMaze Therapeutics Holding  (OTCPK:RLFTY) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

MindMaze Therapeutics Holding PB Ratio Related Terms

MindMaze Therapeutics Holding PB Ratio Historical Data

* Premium members only.

The historical data trend for MindMaze Therapeutics Holding's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindMaze Therapeutics Holding PB Ratio Chart

MindMaze Therapeutics Holding Annual Data
Trend Dec24 Dec25
PB Ratio
0.00 8.95

MindMaze Therapeutics Holding Semi-Annual Data
Dec24 Dec25
PB Ratio 0.00 8.95

RLFTY vs VRTX, REGN, ALNY: PB Ratio Comparison

For the Biotechnology subindustry, MindMaze Therapeutics Holding's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindMaze Therapeutics Holding PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindMaze Therapeutics Holding's PB Ratio distribution charts can be found below:

* The bar in red indicates where MindMaze Therapeutics Holding's PB Ratio falls into.


RLFTY
11GF Score
MindMaze Therapeutics Holding SA RLFTY
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindMaze Therapeutics Holding PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

MindMaze Therapeutics Holding's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=0.4225/0.315
=1.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PB Ratio=Market Cap /(Total Stockholders Equity-Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 1.34 mean?
MindMaze Therapeutics Holding (RLFTY) has a PB Ratio of 1.34 as of Jul. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MindMaze Therapeutics Holding and its competitors. According to the industry distribution chart, MindMaze Therapeutics Holding ranks #166 out of 1228 companies in the Biotechnology industry, placing it in the top 13.5%.
Is MindMaze Therapeutics Holding's PB Ratio too high?
MindMaze Therapeutics Holding's current PB Ratio is 1.34. The Biotechnology industry median PB Ratio is 2.95. MindMaze Therapeutics Holding's value of 1.34 is 54.6% below this industry median. Based on the distribution chart, MindMaze Therapeutics Holding ranks #166 out of 1228 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, MindMaze Therapeutics Holding has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does MindMaze Therapeutics Holding's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MindMaze Therapeutics Holding ranks #166 out of 1228 companies for PB Ratio. This places MindMaze Therapeutics Holding in the top 14% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.95. MindMaze Therapeutics Holding's value of 1.34 is 54.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.95, based on 1,228 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MindMaze Therapeutics Holding's current PB Ratio of 1.34 is 54.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MindMaze Therapeutics Holding and its competitors. For the Biotechnology industry, the median PB Ratio is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MindMaze Therapeutics Holding's current PB Ratio is 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindMaze Therapeutics Holding stock overvalued right now?
MindMaze Therapeutics Holding (RLFTY) has a current PB Ratio of 1.34. The current PB Ratio is 1.34 and 54.6% below the Biotechnology industry median of 2.95. MindMaze Therapeutics Holding's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For MindMaze Therapeutics Holding (RLFTY), the current PB Ratio is 1.34 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MindMaze Therapeutics Holding Business Description

Other Exchanges MMTXz:UKMMTX:Switzerland
Address Avenue de Secheron 15, Geneva, CHE, 1202
MindMaze Therapeutics Holding SA is a Swiss-based, commercial-stage biopharmaceutical and neurotechnology company. The company develops and commercializes digital treatments for neurological diseases and brain disorders. Its technology platform integrates software, sensors, and telehealth, and its solutions are used in clinical and home settings internationally. The company has developed evidence-based, next-generation neurotherapeutics that provide evidence-based motor and cognitive treatments to redefine clinical outcomes in patients with neurological disease and brain disorders. The company also manages Relief's existing portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.
11GF Score

Get the complete analysis for RLFTY

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price